<DOC>
	<DOC>NCT02165722</DOC>
	<brief_summary>The purpose of this study is to test whether or not the 4 Pillars Immunization Toolkit increases adolescent vaccination rates, particularly influenza and human papillomavirus (HPV) but also tetanus, diphtheria and pertussis (Tdap), and meningococcal conjugate (MCV) vaccination rates. The vaccines are all FDA licensed vaccines and to be used according to national guidelines. The investigators will conduct a randomized cluster trial of this toolkit in diverse primary care practices with electronic medical records (EMRs).</brief_summary>
	<brief_title>4 Pillars Toolkit for Adolescent Vaccination</brief_title>
	<detailed_description>This intervention is a stratified randomized cluster trial in about 21 diverse primary care practices. These practices will be randomly assigned to be intervention or control sites to test this 4 Pillars Immunization Toolkit intervention package of evidence-based techniques tailored to their practice structure and culture; the specialties are split between pediatric and family medicine practices.</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>For clinical sites: inclusion criterion includes 1. an appropriate adolescent population: e.g., adolescents aged 11 to 17 years 2. currently using an EMR 3. having and keeping immunization data within a EMR or registry. For clinical sites: the exclusion criteria is consistent SOP use for the vaccines being studied or known much higher than average immunization rates.</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Influenza</keyword>
	<keyword>HPV</keyword>
	<keyword>Tdap</keyword>
	<keyword>MCV</keyword>
	<keyword>vaccination</keyword>
	<keyword>adolescents</keyword>
</DOC>